RT Chen, CY Liu, SY Lin, CC Shu, WH Sheng - Scientific Reports, 2024 - nature.com
Regarding clinically-concerning non-standard initial anti-tuberculous (TB) regimens, few
studies have examined their prevalence, risk factors and impacts. We recruited patients with …